proteom
analysi
perform
screen
potenti
latent
tuberculosi
infect
ltbi
biomark
train
set
spectra
use
gener
diagnost
model
blind
test
set
use
determin
accuraci
model
candid
peptid
identifi
use
nanoliquid
chromatographyelectrospray
ionizationtandem
mass
spectrometri
base
train
set
result
diagnost
model
recogn
ltbi
subject
good
crossvalid
accuraci
blind
test
set
ltbi
subject
could
identifi
sensit
specif
respect
addit
potenti
ltbi
biomark
identifi
protein
identifi
first
time
proteom
plasma
healthi
latent
infect
individu
proteom
pattern
analys
increas
accuraci
ltbi
diagnosi
data
present
provid
novel
insight
potenti
mechan
involv
ltbi
tuberculosi
tb
major
caus
mortal
worldwid
caus
estim
million
death
year
global
number
new
case
million
higher
time
histori
lawn
zumla
peopl
infect
mycobacterium
tuberculosi
mtb
retain
initi
infect
develop
latent
tb
state
character
evid
immun
respons
bacterium
sign
activ
infect
latent
tb
maintain
lifetim
infect
person
howev
mtb
bacilli
persist
symptomfre
individu
reactiv
caus
activ
diseas
approxim
infect
lifetim
jasmer
et
al
pai
et
al
tufariello
et
al
estim
onethird
world
popul
infect
mtb
dye
et
al
larg
reservoir
individu
latent
tb
infect
ltbi
pose
hurdl
tb
elimin
cdc
sterl
et
al
sterl
et
al
nearli
centuri
tuberculin
skin
test
tst
avail
test
detect
ltbi
howev
tst
limit
includ
low
sensit
immunocompromis
patient
crossreact
bacil
vaccin
environment
mycobacteria
need
second
visit
often
result
miss
followup
menzi
decad
ago
releas
assay
igra
develop
titr
measur
invitro
stimul
peripher
blood
mononuclear
cell
antigen
earli
secret
antigen
target
cultur
filtrat
protein
igra
becom
gold
standard
identifi
individu
whose
immun
system
previous
encount
mtb
lawn
zumla
howev
sensit
assay
remain
limit
sester
et
al
higher
materi
cost
igra
need
laboratori
infrastructur
train
personnel
venipunctur
field
condit
pose
seriou
practic
limit
particularli
highburden
resourcelimit
countri
date
communitybas
survey
perform
use
igra
addit
mechan
involv
maintain
latent
infect
complex
mani
fundament
question
regard
mechan
remain
unansw
consequ
need
better
biomark
diagnos
ltbi
greater
understand
ltbi
pathogenesi
discoveri
biomark
bodi
fluid
advanc
develop
highthroughput
spectrometr
method
faulkner
et
al
fertin
et
al
particularli
magnet
bead
combin
matrixassist
laser
desorptionion
timeofflight
mass
spectrometri
malditof
ms
promis
highthroughput
approach
identifi
new
potenti
biomark
variou
bodi
fluid
magnet
bead
larg
surfac
area
captur
lowabund
peptid
protein
combin
magnet
bead
malditof
ms
leverag
advantag
method
therefor
reduc
complex
enrich
lowabund
protein
huang
et
al
technic
perform
affin
bead
purif
similar
enzymelink
immunosorb
assay
use
process
mani
sampl
parallel
cheng
et
al
mani
protein
biomark
diseas
identifi
use
diagnost
microbiolog
infecti
diseas
techniqu
dekker
et
al
fiedler
et
al
komori
et
al
schwamborn
et
al
previous
studi
demonstr
proteom
pattern
base
profil
distinguish
activ
tb
nontb
individu
deng
et
al
howev
remain
lack
publish
data
use
method
tool
biomark
discoveri
ltbi
studi
appli
magnet
bead
combin
malditof
ms
analyz
plasma
sampl
healthi
latent
infect
individu
healthi
mtbnoninfect
control
infectionassoci
biomark
aim
determin
diagnost
accuraci
put
peptid
biomark
better
understand
ltbi
pathogenesi
studi
conduct
accord
principl
declar
helsinki
approv
ethic
committe
capit
medic
universitybeij
chest
hospit
particip
least
year
old
hiv
neg
provid
written
inform
consent
subject
prospect
enrol
recruit
staff
beij
chest
hospit
capit
medic
univers
china
june
octob
healthi
latent
infect
subject
recruit
close
contact
activ
tb
patient
posit
tst
tspottb
test
normal
chest
comput
tomographi
ct
clinic
symptom
evid
activ
tb
clinic
evid
diseas
nontubercul
respiratori
infect
lung
cancer
lu
et
al
shao
et
al
healthi
mtbnoninfect
control
recruit
peopl
exposur
mtb
neg
tst
tspottb
test
normal
chest
ct
clinic
evid
diseas
individu
exclud
prior
histori
tb
anoth
infecti
diseas
histori
diabet
hepat
b
viru
hbv
posit
hepat
c
viru
hcv
posit
diseas
highli
preval
china
refus
unabl
give
consent
cours
studi
healthi
particip
ltbi
healthi
particip
tb
infect
control
enrol
particip
exclud
studi
follow
reason
histori
tb
anoth
infecti
diseas
n
hbvor
hcvposit
individu
n
histori
diabet
n
final
studi
sampl
compris
subject
individu
ltbi
healthi
control
analyz
peptidom
fingerprint
train
set
ltbi
individu
healthi
control
model
gener
design
ltbi
individu
healthi
control
blind
test
set
valid
fig
demograph
featur
train
blind
test
set
summar
tabl
particip
underw
standard
interview
physic
examin
chest
ct
sputum
smear
tst
test
commerci
igrath
tspottb
test
oxford
immunotech
oxford
uk
complet
blood
count
abbott
axsym
antihbsag
hcv
antibodi
assay
kit
abbott
laboratori
chicago
il
usa
diagnosi
ltbi
defin
accord
guidelin
nation
institut
health
clinic
excel
nation
institut
health
clinic
excel
close
contact
activ
tb
posit
tst
tspottb
test
absenc
clinic
radiolog
microbiolog
evid
activ
tb
team
tb
physician
radiologist
review
avail
medic
record
disagr
regard
diagnosi
third
physician
radiologist
refere
radiologist
blind
result
test
sampl
collect
process
accord
feasibl
highli
standard
preanalyt
protocol
baumann
et
al
collect
ml
heparin
plasma
particip
obtain
fresh
plasma
centrifug
blood
specimen
g
min
room
temperatur
within
h
collect
plasma
aliquot
ml
polypropylen
tube
immedi
freez
sampl
avoid
freezethaw
cycl
recommend
world
health
organ
standard
mantoux
techniqu
tst
administ
train
nurs
use
ml
tuberculin
unit
purifi
protein
deriv
rt
staten
serum
institut
copenhagen
denmark
test
read
h
later
use
diamet
cutoff
point
reduc
variat
read
doubleblind
read
perform
independ
reader
use
averag
measur
analysi
blood
tspottb
test
collect
tst
applic
tspottb
test
perform
accord
manufactur
instruct
oxford
immunotec
oxford
uk
peripher
blood
mononuclear
cell
pbmc
isol
centrifug
wash
twice
resuspend
gibco
aimv
invitrogen
auckland
new
zealand
pbmc
stimul
plate
incub
overnight
co
incub
well
wash
time
phosphat
buffer
solut
incub
h
monoclon
antibodi
conjug
alkalinephosphatas
wash
time
ad
chromogen
substrat
presenc
reactiv
antigenspecif
cell
reveal
spot
well
autom
spot
count
perform
use
ctl
elispot
system
versa
analyz
cleveland
oh
usa
result
record
base
definit
posit
neg
reaction
given
instruct
manufactur
respons
score
posit
test
well
contain
mean
least
spotform
cell
mean
neg
control
well
number
least
twice
mean
neg
control
well
sampl
fraction
use
weak
cation
exchang
magnet
bead
mbwcx
accord
manufactur
recommend
bruker
dalton
bremen
germani
briefli
suspens
magnet
bead
mix
shake
elut
beat
mbwcx
separ
protein
elut
peptid
sampl
transfer
clean
sampl
tube
ms
analysi
five
microlit
acid
substrat
solut
gl
dissolv
aceton
ethanol
elut
mix
next
mixtur
appli
metal
target
plate
dri
room
temperatur
final
prepar
sampl
analyz
malditof
ms
bruker
dalton
rang
da
peptid
molecular
weight
collect
shot
laser
energi
use
evalu
precis
assay
withinrun
betweenrun
variat
determin
use
multipl
analys
bead
fraction
ms
plasma
sampl
assess
withinrun
variabl
plasma
sampl
load
onto
spot
assess
betweenrun
variabl
ident
sampl
assay
time
independ
profil
peak
differ
molecular
mass
select
evalu
withinrun
betweenrun
coeffici
varianc
cv
peptid
plasma
sampl
elut
magnet
bead
analyz
nanoliquid
chromatographyelectrospray
ionizationtandem
mass
spectrometri
nanolcesimsm
system
consist
aquiti
uplc
system
water
linear
ion
trap
quadrupol
ltq
obitrap
xl
mass
spectromet
thermo
fisher
equip
nanoesi
sourc
peptid
load
trap
column
nanoacqu
mm
symmetri
flow
rate
desalt
peptid
analyz
analyt
column
nanoacqu
mm
symmetri
flow
rate
nlmin
mobil
phase
acetonitril
formic
acid
b
acetonitril
formic
acid
use
analyt
column
gradient
elut
profil
follow
b
min
ms
instrument
oper
datadepend
model
rang
full
scan
da
mass
resolut
intens
monoisotop
ion
use
precursor
collisioninduc
dissoci
sampl
run
sodium
dodecyl
sulfatepolyacrylamid
gel
transfer
onto
polyvinyliden
difluorid
membran
millipor
corpor
billerica
usa
electroblot
block
h
trisbuff
salinet
buffer
mmoll
trishcl
mmoll
nacl
tween
contain
skim
milk
primari
antibodi
use
rabbit
antifibrinogen
alpha
chain
antibodi
dilut
abcam
cambridg
usa
mous
antitransketolas
antibodi
dilut
abcam
rabbit
antiperoxiredoxini
antibodi
dilut
abcam
rabbit
antiubiquitinlik
modifi
activ
enzym
dilut
abcam
rabbit
antitcomplex
protein
subunit
beta
antibodi
dilut
abcam
rabbit
antibodi
dilut
abcam
membran
incub
room
temperatur
h
primari
antibodi
wash
time
incub
horseradish
peroxidaseconjug
antirabbit
igg
dilut
santa
cruz
biotechnolog
santa
cruz
ca
usa
antimous
igg
dilut
santa
cruz
biotechnolog
h
room
temperatur
reaction
detect
chemiluminesc
electrochemiluminesc
kit
amersham
bioscienc
buckinghamshir
uk
recommend
manufactur
protein
level
result
spectra
analyz
use
clinprotool
clinprot
softwar
version
bruker
dalton
peak
interest
select
total
averag
spectra
use
signaltonois
threshold
align
spectra
mass
shift
determin
profil
gener
leav
crossvalid
process
perform
within
softwar
comparison
rel
peak
intens
level
class
also
calcul
within
softwar
suit
student
test
use
analyz
normal
distribut
continu
data
wherea
wilcoxon
test
use
nonnorm
distribut
continu
data
chisquar
test
use
categor
data
analysi
p
b
consid
statist
signific
genet
algorithm
ga
supervis
neural
network
snn
quick
classifi
qc
algorithm
contain
softwar
suit
use
establish
model
identifi
ltbi
individu
healthi
control
model
perform
train
set
valid
blind
test
set
receiv
oper
characterist
roc
curv
area
curv
auc
analys
use
determin
diagnost
efficaci
singl
marker
model
mass
rang
analyz
da
peptid
detect
signaltonois
threshold
peak
significantli
differ
ltbi
individu
healthi
control
p
b
preliminari
statist
analysi
perform
peak
roc
analysi
auc
peak
masstocharg
ratio
mz
peak
mz
peak
mz
confid
interv
ci
ci
ci
respect
correspond
highli
accur
test
auc
peak
mz
peak
mz
ci
ci
respect
correspond
moder
accur
test
peak
roc
p
valu
auc
valu
depict
separ
fig
overal
spectra
ltbi
individu
healthi
control
display
fig
show
protein
profil
kda
determin
precis
assay
withinrun
betweenrun
reproduc
sampl
evalu
data
cv
withinrun
betweenrun
assay
summar
tabl
onlin
data
supplement
mean
cv
run
repres
overal
imprecis
withinrun
betweenrun
assay
indic
result
produc
method
highli
reproduc
train
set
differ
classif
model
ltbi
individu
healthi
control
gener
use
ga
snn
qc
algorithm
use
pair
peak
yield
best
perform
ga
snn
qc
model
perform
reason
well
train
set
discrimin
control
ltbi
sampl
crossvalid
accuraci
recognit
capabl
respect
peak
select
model
provid
tabl
assess
accuraci
valid
classif
model
deriv
train
set
appli
model
blind
test
set
consist
ltbi
individu
healthi
control
model
also
perform
well
test
set
sensit
specif
tabl
roc
analysi
ga
snn
qc
model
auc
model
train
set
blind
test
set
ci
ci
ci
ci
ci
ci
respect
correspond
highli
accur
test
suggest
ltbi
individu
healthi
control
welldiscrimin
model
fig
identifi
peptid
observ
ms
profil
possibl
biomark
ltbi
attempt
identifi
mani
detect
peak
possibl
peak
ga
snn
qc
model
select
protein
identif
use
ltqorbitrapm
detect
differenti
express
peptid
success
identifi
tabl
valid
result
studi
western
blot
use
examin
express
peroxiredoxini
prxi
transketolas
tkt
fibrinogen
alpha
chain
fga
ubiquitinlik
modifi
activ
enzym
tcomplex
protein
subunit
beta
shown
fig
protein
western
blot
result
show
pattern
express
obtain
proteom
data
significantli
higher
level
p
tkt
p
fga
p
p
found
ltbi
individu
compar
healthi
control
lower
level
prxi
p
p
found
ltbi
individu
compar
healthi
control
statist
signific
tabl
peak
select
algorithm
model
algorithm
peak
select
mz
snn
qc
ga
studi
demonstr
magnet
bead
combin
malditof
ms
could
differenti
healthi
latent
infect
individu
healthi
mtbnoninfect
control
high
sensit
specif
clinprot
wellestablish
system
enabl
proteom
profil
use
bioinformat
softwar
clinprotool
provid
algorithm
multivari
statist
analys
improv
detect
candid
peak
ishigami
et
al
sandhu
et
al
publish
report
demonstr
activ
tb
accur
distinguish
ltbi
symptomat
patient
use
surfaceenhanc
laser
desorptionion
timeofflight
mass
spectrometri
selditofm
unfortun
research
identifi
distinguish
protein
major
drawback
selditofm
approach
retain
protein
directli
recov
proteinchip
array
moreov
chiptochip
variat
anoth
obstacl
seldi
analysi
overcom
problem
magnet
beadbas
plasma
profil
method
develop
studi
method
leav
suffici
materi
subsequ
protein
identif
experi
reduc
assaytoassay
researchertoresearch
variat
use
function
magnet
bead
autom
machin
wong
et
al
studi
identifi
plasma
protein
subject
ltbi
nanolcesimsm
compar
healthi
control
protein
upregul
protein
downregul
ltbi
individu
knowledg
protein
identifi
first
time
proteom
plasma
healthi
latent
infect
individu
select
descript
protein
may
involv
ltbi
pathogenesi
discuss
follow
found
mani
acut
phase
protein
app
plasma
subject
ltbi
protein
may
take
part
inflamm
control
implic
activ
innat
immun
respons
infect
mtb
suggest
inflammatori
respons
may
play
import
role
ltbi
among
app
found
ltbi
fibrinogen
necessari
cofactor
toxic
proinflammatori
activ
fibrinogen
includ
fragment
fibrinogen
chain
studi
demonstr
fibrinogen
chain
precursor
best
discrimin
ga
snn
qc
model
select
protein
possibl
fibrinogen
chain
associ
inflammatori
respons
mtb
chain
fibrinogen
liu
et
al
found
fibrinogen
upregul
proteom
profil
tb
pericardi
effus
propos
fibrinogen
may
significantli
involv
etiolog
tubercul
pericardi
effus
studi
vivo
mice
model
mycobacteri
granuloma
format
observ
fibrinogen
promot
granul
tissu
format
suppress
leukocyt
necrosi
sakamoto
et
al
present
studi
found
fibrinogen
chain
precursor
significantli
increas
plasma
ltbi
individu
result
investig
indic
fibrinogen
andor
fragment
may
involv
pathophysiolog
mechan
tb
ltbi
may
serv
use
marker
interalphatrypsin
inhibitor
heavi
chain
anoth
posit
app
relat
cell
prolifer
migrat
develop
acutephas
respons
involv
infect
inflamm
previou
studi
posit
marker
proteom
fingerprint
studi
chronic
obstruct
pulmonari
diseas
bandow
et
al
dairi
calv
experiment
induc
pneumonia
et
al
apolipoprotein
ai
apoai
belong
neg
app
play
major
role
transport
nutrient
hormon
metabolit
apoai
major
compon
highdens
lipoprotein
declin
highdens
lipoprotein
render
host
tissu
suscept
bacteri
substancemedi
injuri
result
cytokin
overproduct
deplet
high
densiti
lipoprotein
viciou
cycl
apoai
demonstr
neg
marker
sever
acut
respiratori
syndrom
wan
et
al
unclear
protein
downregul
ltbi
mikkat
et
al
shown
concentr
neg
app
decreas
respons
infect
inflamm
increas
transcapillari
escap
catabol
rate
decad
although
product
app
agentspecif
level
express
use
biolog
marker
tissu
injuri
onset
progress
varieti
diseas
process
endeman
et
al
cordero
et
al
app
gener
system
respons
acut
inflammatori
stimuli
also
chronic
inflamm
thu
util
identifi
app
marker
predict
activ
tb
inflammatori
diseas
studi
includ
activ
tb
inflammatori
diseas
studi
need
confirm
predict
immun
respons
mtb
drive
bacteria
latent
state
upregul
ltbi
individu
mediat
human
hlaf
adjac
transcript
modif
significantli
involv
immun
respons
aichem
et
al
hlaf
adjac
transcript
express
induc
tissu
necrosi
factor
crucial
protect
immun
mycobacteria
tufariello
et
al
anoth
upregul
enzym
leukotrien
member
zincindepend
medium
chain
dehydrogenas
reductas
famili
enzym
might
induc
enhanc
degrad
prostaglandin
promot
cell
prolifer
product
cell
thu
possibl
particip
immun
respons
mtb
tb
associ
oxid
stress
induct
host
antioxid
counteract
respons
studi
antioxid
enzym
prxi
tkt
identifi
plasma
individu
ltbi
tkt
serv
revers
link
oxid
branch
pentos
phosphat
pathway
glycolysi
critic
enzym
cellular
defens
oxid
damag
lassen
et
al
observ
upregul
express
tkt
impli
import
role
antioxid
prxi
belong
ubiquit
peroxiredoxin
famili
shown
multipl
function
enhanc
natur
killer
cell
activ
increas
cell
resist
oxid
stress
regul
transcript
activ
protein
protect
erythrocyt
oxid
stress
chen
et
al
current
data
show
prxi
level
ltbi
individu
lower
healthi
control
suggest
capac
self
protect
impair
ltbi
individu
respons
oxid
stress
presenc
antioxid
enzym
plasma
ltbi
individu
indic
antioxid
respons
import
effect
mtbinduc
oxid
injuri
conclus
preliminari
data
studi
suggest
malditof
ms
combin
magnet
bead
bioinformat
tool
effect
technolog
construct
diagnost
model
particular
power
model
could
accur
differenti
healthi
latent
infect
individu
healthi
mtbnoninfect
control
howev
present
studi
preliminari
research
studi
increas
sampl
size
includ
inflammatori
diseas
control
group
need
confirm
result
especi
subsequ
valid
discov
protein
addit
potenti
ltbi
biomark
identifi
identifi
protein
might
particip
regul
inflammatori
antioxid
host
immun
respons
mtb
note
measur
plasma
protein
level
technic
much
easier
approach
igra
offer
econom
effect
initi
detect
tool
clinic
set
hope
valid
plasmat
profil
ltbi
provid
inform
ltbiassoci
target
process
pathogenesi
supplementari
data
articl
found
onlin
http
dx
